324 related articles for article (PubMed ID: 25458418)
1. Cholesterol and breast cancer pathophysiology.
Nelson ER; Chang CY; McDonnell DP
Trends Endocrinol Metab; 2014 Dec; 25(12):649-55. PubMed ID: 25458418
[TBL] [Abstract][Full Text] [Related]
2. Re-adopting classical nuclear receptors by cholesterol metabolites.
Umetani M
J Steroid Biochem Mol Biol; 2016 Mar; 157():20-6. PubMed ID: 26563834
[TBL] [Abstract][Full Text] [Related]
3. Liver X receptor as a drug target for the treatment of breast cancer.
Wu Y; Yu DD; Yan DL; Hu Y; Chen D; Liu Y; Zhang HD; Yu SR; Cao HX; Feng JF
Anticancer Drugs; 2016 Jun; 27(5):373-82. PubMed ID: 26872310
[TBL] [Abstract][Full Text] [Related]
4. 27-Hydroxycholesterol, an endogenous selective estrogen receptor modulator.
He S; Nelson ER
Maturitas; 2017 Oct; 104():29-35. PubMed ID: 28923174
[TBL] [Abstract][Full Text] [Related]
5. 27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth.
Wu Q; Ishikawa T; Sirianni R; Tang H; McDonald JG; Yuhanna IS; Thompson B; Girard L; Mineo C; Brekken RA; Umetani M; Euhus DM; Xie Y; Shaul PW
Cell Rep; 2013 Nov; 5(3):637-45. PubMed ID: 24210818
[TBL] [Abstract][Full Text] [Related]
6. Circulating 27-hydroxycholesterol and breast cancer tissue expression of CYP27A1, CYP7B1, LXR-β, and ERβ: results from the EPIC-Heidelberg cohort.
Le Cornet C; Walter B; Sookthai D; Johnson TS; Kühn T; Herpel E; Kaaks R; Fortner RT
Breast Cancer Res; 2020 Feb; 22(1):23. PubMed ID: 32075687
[TBL] [Abstract][Full Text] [Related]
7. Obesity, cholesterol metabolism, and breast cancer pathogenesis.
McDonnell DP; Park S; Goulet MT; Jasper J; Wardell SE; Chang CY; Norris JD; Guyton JR; Nelson ER
Cancer Res; 2014 Sep; 74(18):4976-82. PubMed ID: 25060521
[TBL] [Abstract][Full Text] [Related]
8. ER-Negative Breast Cancer Is Highly Responsive to Cholesterol Metabolite Signalling.
Hutchinson SA; Lianto P; Roberg-Larsen H; Battaglia S; Hughes TA; Thorne JL
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31683867
[TBL] [Abstract][Full Text] [Related]
9. 27-Hydroxycholesterol: a potential endogenous regulator of estrogen receptor signaling.
DuSell CD; McDonnell DP
Trends Pharmacol Sci; 2008 Oct; 29(10):510-4. PubMed ID: 18722677
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiological role of 27-hydroxycholesterol in human diseases.
Kim D; Lee KM; Lee C; Jo YS; Muradillaevna MS; Kim JH; Yoon JH; Song P
Adv Biol Regul; 2022 Jan; 83():100837. PubMed ID: 34774482
[TBL] [Abstract][Full Text] [Related]
11. The significance of cholesterol and its metabolite, 27-hydroxycholesterol in breast cancer.
Nelson ER
Mol Cell Endocrinol; 2018 May; 466():73-80. PubMed ID: 28919300
[TBL] [Abstract][Full Text] [Related]
12. 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology.
Nelson ER; Wardell SE; Jasper JS; Park S; Suchindran S; Howe MK; Carver NJ; Pillai RV; Sullivan PM; Sondhi V; Umetani M; Geradts J; McDonnell DP
Science; 2013 Nov; 342(6162):1094-8. PubMed ID: 24288332
[TBL] [Abstract][Full Text] [Related]
13. 27-Hydroxycholesterol acts on myeloid immune cells to induce T cell dysfunction, promoting breast cancer progression.
Ma L; Wang L; Nelson AT; Han C; He S; Henn MA; Menon K; Chen JJ; Baek AE; Vardanyan A; Shahoei SH; Park S; Shapiro DJ; Nanjappa SG; Nelson ER
Cancer Lett; 2020 Nov; 493():266-283. PubMed ID: 32861706
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of the estrogen receptor agonist estradiol on toxicity induced by enzymatically-derived or autoxidation-derived oxysterols in human ARPE-19 cells.
Dasari B; Prasanthi JR; Meiers C; Singh BB; Ghribi O
Curr Eye Res; 2013 Nov; 38(11):1159-71. PubMed ID: 23841471
[TBL] [Abstract][Full Text] [Related]
15. Our evolving understanding of how 27-hydroxycholesterol influences cancer.
Ma L; Cho W; Nelson ER
Biochem Pharmacol; 2022 Feb; 196():114621. PubMed ID: 34043965
[TBL] [Abstract][Full Text] [Related]
16. The Cholesterol Metabolite 27HC Increases Secretion of Extracellular Vesicles Which Promote Breast Cancer Progression.
Baek AE; Krawczynska N; Das Gupta A; Dvoretskiy SV; You S; Park J; Deng YH; Sorrells JE; Smith BP; Ma L; Nelson AT; McDowell HB; Sprenger A; Henn MA; Madak-Erdogan Z; Kong H; Boppart SA; Boppart MD; Nelson ER
Endocrinology; 2021 Jul; 162(7):. PubMed ID: 33959755
[TBL] [Abstract][Full Text] [Related]
17. Uncoupling nuclear receptor LXR and cholesterol metabolism in cancer.
Bovenga F; Sabbà C; Moschetta A
Cell Metab; 2015 Apr; 21(4):517-26. PubMed ID: 25863245
[TBL] [Abstract][Full Text] [Related]
18. The cholesterol metabolite 27-hydroxycholesterol promotes atherosclerosis via proinflammatory processes mediated by estrogen receptor alpha.
Umetani M; Ghosh P; Ishikawa T; Umetani J; Ahmed M; Mineo C; Shaul PW
Cell Metab; 2014 Jul; 20(1):172-82. PubMed ID: 24954418
[TBL] [Abstract][Full Text] [Related]
19. The contribution of cholesterol and epigenetic changes to the pathophysiology of breast cancer.
Munir MT; Ponce C; Powell CA; Tarafdar K; Yanagita T; Choudhury M; Gollahon LS; Rahman SM
J Steroid Biochem Mol Biol; 2018 Oct; 183():1-9. PubMed ID: 29733910
[TBL] [Abstract][Full Text] [Related]
20. 27-hydroxycholesterol is an endogenous selective estrogen receptor modulator.
DuSell CD; Umetani M; Shaul PW; Mangelsdorf DJ; McDonnell DP
Mol Endocrinol; 2008 Jan; 22(1):65-77. PubMed ID: 17872378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
